Regulation of molecular chaperones through post-translational modifications: Decrypting the chaperone code

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1829, Issue 5, 2013, Pages 443-454

  Cloutier, Philippe ^a   Coulombe, Benoit ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Hsp70; Hsp90; Molecular chaperone; Post translational modification; VCP

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; ISOPROTEIN; MULTIPROTEIN COMPLEX; PROTEIN KINASE B; PROTEIN P97; UBIQUITIN;

ENZYME SPECIFICITY; GLUTATHIONYLATION; HISTONE ACETYLATION; HUMAN; MOLECULAR EVOLUTION; NITROSYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; UBIQUITINATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL CYCLE PROTEINS; HEAT-SHOCK PROTEINS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84875498382     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2013.02.010     Document Type: Review

References (198)

1. Tissieres A., Mitchell H.K., Tracy U.M. Protein synthesis in salivary glands of Drosophila melanogaster: relation to chromosome puffs. J. Mol. Biol. 1974, 84:389-398.
2. Frydman J., Nimmesgern E., Ohtsuka K., Hartl F.U. Folding of nascent polypeptide chains in a high molecular mass assembly with molecular chaperones. Nature 1994, 370:111-117.
3. Gambill B.D., Voos W., Kang P.J., Miao B., Langer T., Craig E.A., Pfanner N. A dual role for mitochondrial heat shock protein 70 in membrane translocation of preproteins. J. Cell Biol. 1993, 123:109-117.
4. Nguyen T.H., Law D.T., Williams D.B. Binding protein BiP is required for translocation of secretory proteins into the endoplasmic reticulum in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:1565-1569.
5. Shi Y., Thomas J.O. The transport of proteins into the nucleus requires the 70-kilodalton heat shock protein or its cytosolic cognate. Mol. Cell. Biol. 1992, 12:2186-2192.
6. Mayer M.P., Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell. Mol. Life Sci. 2005, 62:670-684.
7. Baler R., Zou J., Voellmy R. Evidence for a role of Hsp70 in the regulation of the heat shock response in mammalian cells. Cell Stress Chaperones 1996, 1:33-39.
8. Vos M.J., Hageman J., Carra S., Kampinga H.H. Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 2008, 47:7001-7011.
9. Chen S., Sullivan W.P., Toft D.O., Smith D.F. Differential interactions of p23 and the TPR-containing proteins Hop, Cyp40, FKBP52 and FKBP51 with Hsp90 mutants. Cell Stress Chaperones 1998, 3:118-129.
10. Liu F.H., Wu S.J., Hu S.M., Hsiao C.D., Wang C. Specific interaction of the 70-kDa heat shock cognate protein with the tetratricopeptide repeats. J. Biol. Chem. 1999, 274:34425-34432.
11. Laufen T., Mayer M.P., Beisel C., Klostermeier D., Mogk A., Reinstein J., Bukau B. Mechanism of regulation of hsp70 chaperones by DnaJ cochaperones. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:5452-5457.
12. Liberek K., Marszalek J., Ang D., Georgopoulos C., Zylicz M. Escherichia coli DnaJ and GrpE heat shock proteins jointly stimulate ATPase activity of DnaK. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:2874-2878.
13. Dragovic Z., Broadley S.A., Shomura Y., Bracher A., Hartl F.U. Molecular chaperones of the Hsp110 family act as nucleotide exchange factors of Hsp70s. EMBO J. 2006, 25:2519-2528.
14. Hohfeld J., Jentsch S. GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein BAG-1. EMBO J. 1997, 16:6209-6216.
15. Raviol H., Sadlish H., Rodriguez F., Mayer M.P., Bukau B. Chaperone network in the yeast cytosol: Hsp110 is revealed as an Hsp70 nucleotide exchange factor. EMBO J. 2006, 25:2510-2518.
16. Johnson B.D., Schumacher R.J., Ross E.D., Toft D.O. Hop modulates Hsp70/Hsp90 interactions in protein folding. J. Biol. Chem. 1998, 273:3679-3686.
17. Connell P., Ballinger C.A., Jiang J., Wu Y., Thompson L.J., Hohfeld J., Patterson C. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell Biol. 2001, 3:93-96.
18. Ramp U., Mahotka C., Heikaus S., Shibata T., Grimm M.O., Willers R., Gabbert H.E. Expression of heat shock protein 70 in renal cell carcinoma and its relation to tumor progression and prognosis. Histol. Histopathol. 2007, 22:1099-1107.
19. Ricaniadis N., Kataki A., Agnantis N., Androulakis G., Karakousis C.P. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Eur. J. Surg. Oncol. 2001, 27:88-93.
20. Maehara Y., Oki E., Abe T., Tokunaga E., Shibahara K., Kakeji Y., Sugimachi K. Overexpression of the heat shock protein HSP70 family and p53 protein and prognosis for patients with gastric cancer. Oncology 2000, 58:144-151.
21. Goloudina A.R., Demidov O.N., Garrido C. Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett. 2012, 325:117-124.
22. Leu J.I., Pimkina J., Frank A., Murphy M.E., George D.L. A small molecule inhibitor of inducible heat shock protein 70. Mol. Cell 2009, 36:15-27.
23. Nylandsted J., Rohde M., Brand K., Bastholm L., Elling F., Jaattela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7871-7876.
24. Bonini N.M. Chaperoning brain degeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(Suppl. 4):16407-16411.
25. Klucken J., Shin Y., Masliah E., Hyman B.T., McLean P.J. Hsp70 reduces alpha-synuclein aggregation and toxicity. J. Biol. Chem. 2004, 279:25497-25502.
26. Gutsmann-Conrad A., Heydari A.R., You S., Richardson A. The expression of heat shock protein 70 decreases with cellular senescence in vitro and in cells derived from young and old human subjects. Exp. Cell Res. 1998, 241:404-413.
27. Njemini R., Abeele M.V., Demanet C., Lambert M., Vandebosch S., Mets T. Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J. Clin. Immunol. 2002, 22:195-205.
28. Ambra R., Mocchegiani E., Giacconi R., Canali R., Rinna A., Malavolta M., Virgili F. Characterization of the hsp70 response in lymphoblasts from aged and centenarian subjects and differential effects of in vitro zinc supplementation. Exp. Gerontol. 2004, 39:1475-1484.
29. Velazquez J.M., Lindquist S. hsp70: nuclear concentration during environmental stress and cytoplasmic storage during recovery. Cell 1984, 36:655-662.
30. Maher P.A., Pasquale E.B. Heat shock induces protein tyrosine phosphorylation in cultured cells. J. Cell Biol. 1989, 108:2029-2035.
31. Knowlton A.A., Grenier M., Kirchhoff S.R., Salfity M. Phosphorylation at tyrosine-524 influences nuclear accumulation of HSP72 with heat stress. Am. J. Physiol. 2000, 278:H2143-H2149.
32. Cvoro A., Dundjerski J., Trajkovic D., Matic G. The level and phosphorylation of Hsp70 in the rat liver cytosol after adrenalectomy and hyperthermia. Cell Biol. Int. 1999, 23:313-320.
33. Staal S.P. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:5034-5037.
34. Altomare D.A., Testa J.R. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005, 24:7455-7464.
35. Rickle A., Bogdanovic N., Volkman I., Winblad B., Ravid R., Cowburn R.F. Akt activity in Alzheimer's disease and other neurodegenerative disorders. Neuroreport 2004, 15:955-959.
36. Zdychova J., Komers R. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol. Res. 2005, 54:1-16.
37. Barati M.T., Rane M.J., Klein J.B., McLeish K.R. A proteomic screen identified stress-induced chaperone proteins as targets of Akt phosphorylation in mesangial cells. J. Proteome Res. 2006, 5:1636-1646.
38. Duriez M., Rossignol J.M., Sitterlin D. The hepatitis B virus precore protein is retrotransported from endoplasmic reticulum (ER) to cytosol through the ER-associated degradation pathway. J. Biol. Chem. 2008, 283:32352-32360.
39. Muller P., Ruckova E., Halada P., Coates P.J., Hrstka R., Lane D.P., Vojtesek B. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances. Oncogene 2012, (Advance online publication).
40. Hwang C.S., Shemorry A., Varshavsky A. N-terminal acetylation of cellular proteins creates specific degradation signals. Science (New York, N.Y.) 2010, 327:973-977.
41. Johnson C.A., White D.A., Lavender J.S., O'Neill L.P., Turner B.M. Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70. J. Biol. Chem. 2002, 277:9590-9597.
42. Nakajima H., Kim Y.B., Terano H., Yoshida M., Horinouchi S. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp. Cell Res. 1998, 241:126-133.
43. Wang Y., Wang S.Y., Zhang X.H., Zhao M., Hou C.M., Xu Y.J., Du Z.Y., Yu X.D. FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70. Biochem. Biophys. Res. Commun. 2007, 356:998-1003.
44. Fortugno P., Beltrami E., Plescia J., Fontana J., Pradhan D., Marchisio P.C., Sessa W.C., Altieri D.C. Regulation of survivin function by Hsp90. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13791-13796.
45. Neckers L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol. Med. 2002, 8:S55-S61.
46. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science (New York, N.Y.) 2009, 325:834-840.
47. Hornbeck P.V., Kornhauser J.M., Tkachev S., Zhang B., Skrzypek E., Murray B., Latham V., Sullivan M. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2012, 40:D261-D270.
48. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L., Zeng Y., Li H., Li Y., Shi J., An W., Hancock S.M., He F., Qin L., Chin J., Yang P., Chen X., Lei Q., Xiong Y., Guan K.L. Regulation of cellular metabolism by protein lysine acetylation. Science (New York, N.Y.) 2010, 327:1000-1004.
49. Kerscher O., Felberbaum R., Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 2006, 22:159-180.
50. Thrower J.S., Hoffman L., Rechsteiner M., Pickart C.M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 2000, 19:94-102.
51. Xu P., Duong D.M., Seyfried N.T., Cheng D., Xie Y., Robert J., Rush J., Hochstrasser M., Finley D., Peng J. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009, 137:133-145.
52. Jiang J., Ballinger C.A., Wu Y., Dai Q., Cyr D.M., Hohfeld J., Patterson C. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J. Biol. Chem. 2001, 276:42938-42944.
53. Kundrat L., Regan L. Identification of residues on Hsp70 and Hsp90 ubiquitinated by the cochaperone CHIP. J. Mol. Biol. 2010, 395:587-594.
54. Morales J.L., Perdew G.H. Carboxyl terminus of hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90kDa heat-shock protein (hsp90) in vitro. Biochemistry 2007, 46:610-621.
55. Qian S.B., McDonough H., Boellmann F., Cyr D.M., Patterson C. CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature 2006, 440:551-555.
56. Moore D.J., West A.B., Dikeman D.A., Dawson V.L., Dawson T.M. Parkin mediates the degradation-independent ubiquitination of Hsp70. J. Neurochem. 2008, 105:1806-1819.
57. Kim W., Bennett E.J., Huttlin E.L., Guo A., Li J., Possemato A., Sowa M.E., Rad R., Rush J., Comb M.J., Harper J.W., Gygi S.P. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 2011, 44:325-340.
58. Shi Y., Chan D.W., Jung S.Y., Malovannaya A., Wang Y., Qin J. A data set of human endogenous protein ubiquitination sites. Mol. Cell. Proteomics 2011, 10. M110, (002089).
59. Wagner S.A., Beli P., Weinert B.T., Nielsen M.L., Cox J., Mann M., Choudhary C. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics 2011, 10. M111, (013284).
60. Grillo M.A., Colombatto S. S-adenosylmethionine and protein methylation. Amino Acids 2005, 28:357-362.
61. Cloos P.A., Christensen J., Agger K., Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 2008, 22:1115-1140.
62. Mosammaparast N., Shi Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 2010, 79:155-179.
63. Wang C., Lin J.M., Lazarides E. Methylations of 70,000-Da heat shock proteins in 3T3 cells: alterations by arsenite treatment, by different stages of growth and by virus transformation. Arch. Biochem. Biophys. 1992, 297:169-175.
64. Wang C., Gomer R.H., Lazarides E. Heat shock proteins are methylated in avian and mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:3531-3535.
65. Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B. A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity. PLoS Genet. 2013, 9:e1003210.
66. Cho H.S., Shimazu T., Toyokawa G., Daigo Y., Maehara Y., Hayami S., Ito A., Masuda K., Ikawa N., Field H.I., Tsuchiya E., Ohnuma S., Ponder B.A., Yoshida M., Nakamura Y., Hamamoto R. Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B. Nat. Commun. 2012, 3:1072.
67. Makhnevych T., Houry W.A. The role of Hsp90 in protein complex assembly. Biochim. Biophys. Acta 2012, 1823:674-682.
68. Zhao R., Davey M., Hsu Y.C., Kaplanek P., Tong A., Parsons A.B., Krogan N., Cagney G., Mai D., Greenblatt J., Boone C., Emili A., Houry W.A. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell 2005, 120:715-727.
69. Eustace B.K., Sakurai T., Stewart J.K., Yimlamai D., Unger C., Zehetmeier C., Lain B., Torella C., Henning S.W., Beste G., Scroggins B.T., Neckers L., Ilag L.L., Jay D.G. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat. Cell Biol. 2004, 6:507-514.
70. Wandinger S.K., Richter K., Buchner J. The Hsp90 chaperone machinery. J. Biol. Chem. 2008, 283:18473-18477.
71. Scheufler C., Brinker A., Bourenkov G., Pegoraro S., Moroder L., Bartunik H., Hartl F.U., Moarefi I. Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine. Cell 2000, 101:199-210.
72. Ali M.M., Roe S.M., Vaughan C.K., Meyer P., Panaretou B., Piper P.W., Prodromou C., Pearl L.H. Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature 2006, 440:1013-1017.
73. Graf C., Stankiewicz M., Kramer G., Mayer M.P. Spatially and kinetically resolved changes in the conformational dynamics of the Hsp90 chaperone machine. EMBO J. 2009, 28:602-613.
74. Hessling M., Richter K., Buchner J. Dissection of the ATP-induced conformational cycle of the molecular chaperone Hsp90. Nat. Struct. Mol. Biol. 2009, 16:287-293.
75. Mickler M., Hessling M., Ratzke C., Buchner J., Hugel T. The large conformational changes of Hsp90 are only weakly coupled to ATP hydrolysis. Nat. Struct. Mol. Biol. 2009, 16:281-286.
76. Panaretou B., Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J. 1998, 17:4829-4836.
77. Shiau A.K., Harris S.F., Southworth D.R., Agard D.A. Structural Analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements. Cell 2006, 127:329-340.
78. Huai Q., Wang H., Liu Y., Kim H.Y., Toft D., Ke H. Structures of the N-terminal and middle domains of E. coli Hsp90 and conformation changes upon ADP binding. Structure 2005, 13:579-590.
79. Johnson J.L., Halas A., Flom G. Nucleotide-dependent interaction of Saccharomyces cerevisiae Hsp90 with the cochaperone proteins Sti1, Cpr6, and Sba1. Mol. Cell. Biol. 2007, 27:768-776.
80. Lee P., Shabbir A., Cardozo C., Caplan A.J. Sti1 and Cdc37 can stabilize Hsp90 in chaperone complexes with a protein kinase. Mol. Biol. Cell 2004, 15:1785-1792.
81. McLaughlin S.H., Sobott F., Yao Z.P., Zhang W., Nielsen P.R., Grossmann J.G., Laue E.D., Robinson C.V., Jackson S.E. The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J. Mol. Biol. 2006, 356:746-758.
82. Panaretou B., Siligardi G., Meyer P., Maloney A., Sullivan J.K., Singh S., Millson S.H., Clarke P.A., Naaby-Hansen S., Stein R., Cramer R., Mollapour M., Workman P., Piper P.W., Pearl L.H., Prodromou C. Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone aha1. Mol. Cell 2002, 10:1307-1318.
83. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 1999, 42:260-266.
84. Neckers L. Heat shock protein 90: the cancer chaperone. J. Biosci. 2007, 32:517-530.
85. Whitesell L., Lindquist S.L. HSP90 and the chaperoning of cancer. Nat. Rev. 2005, 5:761-772.
86. Kim Y.S., Alarcon S.V., Lee S., Lee M.J., Giaccone G., Neckers L., Trepel J.B. Update on Hsp90 inhibitors in clinical trial. Curr. Top. Med. Chem. 2009, 9:1479-1492.
87. Messaoudi S., Peyrat J.F., Brion J.D., Alami M. Recent advances in Hsp90 inhibitors as antitumor agents. Anticancer Agents Med. Chem. 2008, 8:761-782.
88. Neckers L. Chaperoning oncogenes: Hsp90 as a target of geldanamycin. Handbook of Experimental Pharmacology 2006, 259-277.
89. Queitsch C., Sangster T.A., Lindquist S. Hsp90 as a capacitor of phenotypic variation. Nature 2002, 417:618-624.
90. Rutherford S.L., Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature 1998, 396:336-342.
91. Sollars V., Lu X., Xiao L., Wang X., Garfinkel M.D., Ruden D.M. Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nat. Genet. 2003, 33:70-74.
92. Mollapour M., Tsutsumi S., Neckers L. Hsp90 phosphorylation, Wee1 and the cell cycle. Cell cycle (Georgetown, Tex.) 2010, 9:2310-2316.
93. Csermely P., Kahn C.R. The 90-kDa heat shock protein (hsp-90) possesses an ATP binding site and autophosphorylating activity. J. Biol. Chem. 1991, 266:4943-4950.
94. Csermely P., Miyata Y., Schnaider T., Yahara I. Autophosphorylation of grp94 (endoplasmin). J. Biol. Chem. 1995, 270:6381-6388.
95. Zhao Y.G., Gilmore R., Leone G., Coffey M.C., Weber B., Lee P.W. Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J. Biol. Chem. 2001, 276:32822-32827.
96. Lees-Miller S.P., Anderson C.W. Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II. J. Biol. Chem. 1989, 264:2431-2437.
97. Cala S.E. GRP94 hyperglycosylation and phosphorylation in Sf21 cells. Biochim. Biophys. Acta 2000, 1496:296-310.
98. Cala S.E., Jones L.R. GRP94 resides within cardiac sarcoplasmic reticulum vesicles and is phosphorylated by casein kinase II. J. Biol. Chem. 1994, 269:5926-5931.
99. Kurokawa M., Zhao C., Reya T., Kornbluth S. Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias. Mol. Cell. Biol. 2008, 28:5494-5506.
100. Ogiso H., Kagi N., Matsumoto E., Nishimoto M., Arai R., Shirouzu M., Mimura J., Fujii-Kuriyama Y., Yokoyama S. Phosphorylation analysis of 90kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex. Biochemistry 2004, 43:15510-15519.
101. Old W.M., Shabb J.B., Houel S., Wang H., Couts K.L., Yen C.Y., Litman E.S., Croy C.H., Meyer-Arendt K., Miranda J.G., Brown R.A., Witze E.S., Schweppe R.E., Resing K.A., Ahn N.G. Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol. Cell 2009, 34:115-131.
102. Woo S.H., An S., Lee H.C., Jin H.O., Seo S.K., Yoo D.H., Lee K.H., Rhee C.H., Choi E.J., Hong S.I., Park I.C. A truncated form of p23 down-regulates telomerase activity via disruption of Hsp90 function. J. Biol. Chem. 2009, 284:30871-30880.
103. Szyszka R., Kramer G., Hardesty B. The phosphorylation state of the reticulocyte 90-kDa heat shock protein affects its ability to increase phosphorylation of peptide initiation factor 2 alpha subunit by the heme-sensitive kinase. Biochemistry 1989, 28:1435-1438.
104. Salvi M., Trashi E., Cozza G., Franchin C., Arrigoni G., Pinna L.A. Investigation on PLK2 and PLK3 substrate recognition. Biochim. Biophys. Acta 2012, 1824:1366-1373.
105. Deb T.B., Zuo A.H., Wang Y., Barndt R.J., Cheema A.K., Sengupta S., Coticchia C.M., Johnson M.D. Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex. Am. J. Physiol. Cell Physiol. 2011, 300:C1139-C1154.
106. Lees-Miller S.P., Anderson C.W. The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal threonine residues. J. Biol. Chem. 1989, 264:17275-17280.
107. Garcia-Cardena G., Fan R., Shah V., Sorrentino R., Cirino G., Papapetropoulos A., Sessa W.C. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998, 392:821-824.
108. Maxwell A.J. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 2002, 6:101-124.
109. Stalker T.J., Gong Y., Scalia R. The calcium-dependent protease calpain causes endothelial dysfunction in type 2 diabetes. Diabetes 2005, 54:1132-1140.
110. Lei H., Venkatakrishnan A., Yu S., Kazlauskas A. Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. J. Biol. Chem. 2007, 282:9364-9371.
111. Duval M., Le Boeuf F., Huot J., Gratton J.P. Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase. Mol. Biol. Cell 2007, 18:4659-4668.
112. Desjardins F., Delisle C., Gratton J.P. Modulation of the cochaperone AHA1 regulates heat-shock protein 90 and endothelial NO synthase activation by vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2484-2492.
113. Mollapour M., Tsutsumi S., Donnelly A.C., Beebe K., Tokita M.J., Lee M.J., Lee S., Morra G., Bourboulia D., Scroggins B.T., Colombo G., Blagg B.S., Panaretou B., Stetler-Stevenson W.G., Trepel J.B., Piper P.W., Prodromou C., Pearl L.H., Neckers L. Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Mol. Cell 2010, 37:333-343.
114. Xu W., Mollapour M., Prodromou C., Wang S., Scroggins B.T., Palchick Z., Beebe K., Siderius M., Lee M.J., Couvillon A., Trepel J.B., Miyata Y., Matts R., Neckers L. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. Mol. Cell 2012, 47:434-443.
115. Brunati A.M., Contri A., Muenchbach M., James P., Marin O., Pinna L.A. GRP94 (endoplasmin) co-purifies with and is phosphorylated by Golgi apparatus casein kinase. FEBS Lett. 2000, 471:151-155.
116. Pridgeon J.W., Olzmann J.A., Chin L.S., Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 2007, 5:e172.
117. Yu X., Guo Z.S., Marcu M.G., Neckers L., Nguyen D.M., Chen G.A., Schrump D.S. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J. Natl. Cancer Inst. 2002, 94:504-513.
118. Marks P.A., Richon V.M., Rifkind R.A. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 2000, 92:1210-1216.
119. Brinkmann H., Dahler A.L., Popa C., Serewko M.M., Parsons P.G., Gabrielli B.G., Burgess A.J., Saunders N.A. Histone hyperacetylation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts. J. Biol. Chem. 2001, 276:22491-22499.
120. Kovacs J.J., Murphy P.J., Gaillard S., Zhao X., Wu J.T., Nicchitta C.V., Yoshida M., Toft D.O., Pratt W.B., Yao T.P. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell 2005, 18:601-607.
121. Bali P., Pranpat M., Bradner J., Balasis M., Fiskus W., Guo F., Rocha K., Kumaraswamy S., Boyapalle S., Atadja P., Seto E., Bhalla K. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J. Biol. Chem. 2005, 280:26729-26734.
122. Kawaguchi Y., Kovacs J.J., McLaurin A., Vance J.M., Ito A., Yao T.P. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 2003, 115:727-738.
123. Murphy P.J., Morishima Y., Kovacs J.J., Yao T.P., Pratt W.B. Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone. J. Biol. Chem. 2005, 280:33792-33799.
124. Scroggins B.T., Robzyk K., Wang D., Marcu M.G., Tsutsumi S., Beebe K., Cotter R.J., Felts S., Toft D., Karnitz L., Rosen N., Neckers L. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol. Cell 2007, 25:151-159.
125. Yang Y., Rao R., Shen J., Tang Y., Fiskus W., Nechtman J., Atadja P., Bhalla K. Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res. 2008, 68:4833-4842.
126. Abu-Farha M., Lanouette S., Elisma F., Tremblay V., Butson J., Figeys D., Couture J.F. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2. J. Mol. Cell Biol. 2011, 3:301-308.
127. Donlin L.T., Andresen C., Just S., Rudensky E., Pappas C.T., Kruger M., Jacobs E.Y., Unger A., Zieseniss A., Dobenecker M.W., Voelkel T., Chait B.T., Gregorio C.C., Rottbauer W., Tarakhovsky A., Linke W.A. Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization. Genes Dev. 2012, 26:114-119.
128. Stamler J.S., Lamas S., Fang F.C. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 2001, 106:675-683.
129. Martinez-Ruiz A., Villanueva L., Gonzalez de Orduna C., Lopez-Ferrer D., Higueras M.A., Tarin C., Rodriguez-Crespo I., Vazquez J., Lamas S. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8525-8530.
130. Overath T., Kuckelkorn U., Henklein P., Strehl B., Bonar D., Kloss A., Siele D., Kloetzel P.M., Janek K. Mapping of O-GlcNAc Sites of 20S proteasome subunits and Hsp90 by a novel biotin-cystamine tag. Mol. Cell. Proteomics 2012, 11:467-477.
131. Whelan S.A., Lane M.D., Hart G.W. Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling. J. Biol. Chem. 2008, 283:21411-21417.
132. Zhang F., Snead C.M., Catravas J.D. Hsp90 regulates O-linked beta-N-acetylglucosamine transferase: a novel mechanism of modulation of protein O-linked beta-N-acetylglucosamine modification in endothelial cells. Am. J. Physiol. Cell Physiol. 2012, 302:C1786-C1796.
133. Qu D., Mazzarella R.A., Green M. Analysis of the structure and synthesis of GRP94, an abundant stress protein of the endoplasmic reticulum. DNA Cell Biol. 1994, 13:117-124.
134. Feldweg A.M., Srivastava P.K. Molecular heterogeneity of tumor rejection antigen/heat shock protein GP96. Int. J. Cancer 1995, 63:310-314.
135. Wang Q., Song C., Yang X., Li C.C. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP. J. Biol. Chem. 2003, 278:32784-32793.
136. Moir D., Stewart S.E., Osmond B.C., Botstein D. Cold-sensitive cell-division-cycle mutants of yeast: isolation, properties, and pseudoreversion studies. Genetics 1982, 100:547-563.
137. Indig F.E., Partridge J.J., von Kobbe C., Aladjem M.I., Latterich M., Bohr V.A. Werner syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent fashion. J. Struct. Biol. 2004, 146:251-259.
138. Livingstone M., Ruan H., Weiner J., Clauser K.R., Strack P., Jin S., Williams A., Greulich H., Gardner J., Venere M., Mochan T.A., DiTullio R.A., Moravcevic K., Gorgoulis V.G., Burkhardt A., Halazonetis T.D. Valosin-containing protein phosphorylation at Ser784 in response to DNA damage. Cancer Res. 2005, 65:7533-7540.
139. Partridge J.J., Lopreiato J.O., Latterich M., Indig F.E. DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP. Mol. Biol. Cell 2003, 14:4221-4229.
140. Zhang H., Wang Q., Kajino K., Greene M.I. VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells. DNA Cell Biol. 2000, 19:253-263.
141. Dai R.M., Chen E., Longo D.L., Gorbea C.M., Li C.C. Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J. Biol. Chem. 1998, 273:3562-3573.
142. Rape M., Hoppe T., Gorr I., Kalocay M., Richly H., Jentsch S. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 2001, 107:667-677.
143. Shcherbik N., Zoladek T., Nickels J.T., Haines D.S. Rsp5p is required for ER bound Mga2p120 polyubiquitination and release of the processed/tethered transactivator Mga2p90. Curr. Biol. 2003, 13:1227-1233.
144. Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009, 187:875-888.
145. Vesa J., Su H., Watts G.D., Krause S., Walter M.C., Martin B., Smith C., Wallace D.C., Kimonis V.E. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul. Disord. 2009, 19:766-772.
146. Hetzer M., Meyer H.H., Walther T.C., Bilbao-Cortes D., Warren G., Mattaj I.W. Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly. Nat. Cell Biol. 2001, 3:1086-1091.
147. Rabouille C., Kondo H., Newman R., Hui N., Freemont P., Warren G. Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro. Cell 1998, 92:603-610.
148. Uchiyama K., Jokitalo E., Kano F., Murata M., Zhang X., Canas B., Newman R., Rabouille C., Pappin D., Freemont P., Kondo H. VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J. Cell Biol. 2002, 159:855-866.
149. Jarosch E., Taxis C., Volkwein C., Bordallo J., Finley D., Wolf D.H., Sommer T. Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat. Cell Biol. 2002, 4:134-139.
150. Rabinovich E., Kerem A., Frohlich K.U., Diamant N., Bar-Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 2002, 22:626-634.
151. Ye Y., Meyer H.H., Rapoport T.A. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 2001, 414:652-656.
152. Ye Y., Meyer H.H., Rapoport T.A. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 2003, 162:71-84.
153. Shmueli A., Tsai Y.C., Yang M., Braun M.A., Weissman A.M. Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum. Biochem. Biophys. Res. Commun. 2009, 390:758-762.
154. Ye Y., Shibata Y., Yun C., Ron D., Rapoport T.A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 2004, 429:841-847.
155. Zhang X., Shaw A., Bates P.A., Newman R.H., Gowen B., Orlova E., Gorman M.A., Kondo H., Dokurno P., Lally J., Leonard G., Meyer H., van Heel M., Freemont P.S. Structure of the AAA ATPase p97. Mol. Cell 2000, 6:1473-1484.
156. Allen M.D., Buchberger A., Bycroft M. The PUB domain functions as a p97 binding module in human peptide N-glycanase. J. Biol. Chem. 2006, 281:25502-25508.
157. Koegl M., Hoppe T., Schlenker S., Ulrich H.D., Mayer T.U., Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999, 96:635-644.
158. Richly H., Rape M., Braun S., Rumpf S., Hoege C., Jentsch S. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell 2005, 120:73-84.
159. Ernst R., Mueller B., Ploegh H.L., Schlieker C. The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER. Mol. Cell 2009, 36:28-38.
160. Rumpf S., Jentsch S. Functional division of substrate processing cofactors of the ubiquitin-selective Cdc48 chaperone. Mol. Cell 2006, 21:261-269.
161. Zhong X., Pittman R.N. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum. Mol. Genet. 2006, 15:2409-2420.
162. Mehta S.G., Khare M., Ramani R., Watts G.D., Simon M., Osann K.E., Donkervoort S., Dec E., Nalbandian A., Platt J., Pasquali M., Wang A., Mozaffar T., Smith C.D., Kimonis V.E. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia. Clin. Genet. 2012, (Epub ahead of print).
163. Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., Ding J., McCluskey L., Martinez-Lage M., Falcone D., Hernandez D.G., Arepalli S., Chong S., Schymick J.C., Rothstein J., Landi F., Wang Y.D., Calvo A., Mora G., Sabatelli M., Monsurro M.R., Battistini S., Salvi F., Spataro R., Sola P., Borghero G., Galassi G., Scholz S.W., Taylor J.P., Restagno G., Chio A., Traynor B.J. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010, 68:857-864.
164. DeJesus-Hernandez M., Desaro P., Johnston A., Ross O.A., Wszolek Z.K., Ertekin-Taner N., Graff-Radford N.R., Rademakers R., Boylan K. Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS. Neurology 2011, 77:1102-1103.
165. Tiloca C., Ratti A., Pensato V., Castucci A., Soraru G., Del Bo R., Corrado L., Cereda C., D'Ascenzo C., Comi G.P., Mazzini L., Castellotti B., Ticozzi N., Gellera C., Silani V. Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:630. 630, (e631-632).
166. Williams K.L., Solski J.A., Nicholson G.A., Blair I.P. Mutation analysis of VCP in familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33. 1488, (e1415-1486).
167. Abramzon Y., Johnson J.O., Scholz S.W., Taylor J.P., Brunetti M., Calvo A., Mandrioli J., Benatar M., Mora G., Restagno G., Chio A., Traynor B.J. Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:2231.e1-2231.e6.
168. Miller J.W., Smith B.N., Topp S.D., Al-Chalabi A., Shaw C.E., Vance C. Mutation analysis of VCP in British familial and sporadic amyotrophic lateral sclerosis patients. Neurobiol. Aging 2012, 33:2721. (e2721-2722).
169. Djamshidian A., Schaefer J., Haubenberger D., Stogmann E., Zimprich F., Auff E., Zimprich A. A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia. Muscle Nerve 2009, 39:389-391.
170. Weihl C.C., Pestronk A., Kimonis V.E. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia. Neuromuscul. Disord. 2009, 19:308-315.
171. Meyer H.H., Shorter J.G., Seemann J., Pappin D., Warren G. A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J. 2000, 19:2181-2192.
172. Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004, 36:377-381.
173. Halawani D., LeBlanc A.C., Rouiller I., Michnick S.W., Servant M.J., Latterich M. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation. Mol. Cell. Biol. 2009, 29:4484-4494.
174. Weihl C.C., Dalal S., Pestronk A., Hanson P.I. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 2006, 15:189-199.
175. Mizuno Y., Hori S., Kakizuka A., Okamoto K. Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci. Lett. 2003, 343:77-80.
176. Hirabayashi M., Inoue K., Tanaka K., Nakadate K., Ohsawa Y., Kamei Y., Popiel A.H., Sinohara A., Iwamatsu A., Kimura Y., Uchiyama Y., Hori S., Kakizuka A. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 2001, 8:977-984.
177. Klein J.B., Barati M.T., Wu R., Gozal D., Sachleben L.R., Kausar H., Trent J.O., Gozal E., Rane M.J. Akt-mediated valosin-containing protein 97 phosphorylation regulates its association with ubiquitinated proteins. J. Biol. Chem. 2005, 280:31870-31881.
178. Vandermoere F., El Yazidi-Belkoura I., Slomianny C., Demont Y., Bidaux G., Adriaenssens E., Lemoine J., Hondermarck H. The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J. Biol. Chem. 2006, 281:14307-14313.
179. Imamura S., Ojima N., Yamashita M. Cold-inducible expression of the cell division cycle gene CDC48 and its promotion of cell proliferation during cold acclimation in zebrafish cells. FEBS Lett. 2003, 549:14-20.
180. Ficarro S., Chertihin O., Westbrook V.A., White F., Jayes F., Kalab P., Marto J.A., Shabanowitz J., Herr J.C., Hunt D.F., Visconti P.E. Phosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation. J. Biol. Chem. 2003, 278:11579-11589.
181. Lavoie C., Chevet E., Roy L., Tonks N.K., Fazel A., Posner B.I., Paiement J., Bergeron J.J. Tyrosine phosphorylation of p97 regulates transitional endoplasmic reticulum assembly in vitro. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13637-13642.
182. Zhang S.H., Liu J., Kobayashi R., Tonks N.K. Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1. J. Biol. Chem. 1999, 274:17806-17812.
183. Wu J., Katrekar A., Honigberg L.A., Smith A.M., Conn M.T., Tang J., Jeffery D., Mortara K., Sampang J., Williams S.R., Buggy J., Clark J.M. Identification of substrates of human protein-tyrosine phosphatase PTPN22. J. Biol. Chem. 2006, 281:11002-11010.
184. Suzuki T., Park H., Till E.A., Lennarz W.J. The PUB domain: a putative protein-protein interaction domain implicated in the ubiquitin-proteasome pathway. Biochem. Biophys. Res. Commun. 2001, 287:1083-1087.
185. Zhao G., Zhou X., Wang L., Li G., Schindelin H., Lennarz W.J. Studies on peptide:N-glycanase-p97 interaction suggest that p97 phosphorylation modulates endoplasmic reticulum-associated degradation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:8785-8790.
186. Egerton M., Ashe O.R., Chen D., Druker B.J., Burgess W.H., Samelson L.E. VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. EMBO J. 1992, 11:3533-3540.
187. Egerton M., Samelson L.E. Biochemical characterization of valosin-containing protein, a protein tyrosine kinase substrate in hematopoietic cells. J. Biol. Chem. 1994, 269:11435-11441.
188. Madeo F., Schlauer J., Zischka H., Mecke D., Frohlich K.U. Tyrosine phosphorylation regulates cell cycle-dependent nuclear localization of Cdc48p. Mol. Biol. Cell 1998, 9:131-141.
189. Steffan J.S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B.L., Kazantsev A., Schmidt E., Zhu Y.Z., Greenwald M., Kurokawa R., Housman D.E., Jackson G.R., Marsh J.L., Thompson L.M. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001, 413:739-743.
190. Koike M., Fukushi J., Ichinohe Y., Higashimae N., Fujishiro M., Sasaki C., Yamaguchi M., Uchihara T., Yagishita S., Ohizumi H., Hori S., Kakizuka A. Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression. J. Biol. Chem. 2010, 285:21736-21749.
191. Kernstock S., Davydova E., Jakobsson M., Moen A., Pettersen S., Maelandsmo G.M., Egge-Jacobsen W., Falnes P.O. Lysine methylation of VCP by a member of a novel human protein methyltransferase family. Nat. Commun. 2012, 3:1038.
192. Mori-Konya C., Kato N., Maeda R., Yasuda K., Higashimae N., Noguchi M., Koike M., Kimura Y., Ohizumi H., Hori S., Kakizuka A. p97/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation. Genes Cells 2009, 14:483-497.
193. Orme C.M., Bogan J.S. The ubiquitin regulatory X (UBX) domain-containing protein TUG regulates the p97 ATPase and resides at the endoplasmic reticulum-golgi intermediate compartment. J. Biol. Chem. 2012, 287:6679-6692.
194. Thiele W., Novac N., Mink S., Schreiber C., Plaumann D., Fritzmann J., Cremers N., Rothley M., Schwager C., Regiert T., Huber P.E., Stein U., Schlag P., Moll J., Abdollahi A., Sleeman J.P. Discovery of a novel tumour metastasis-promoting gene, NVM-1. J. Pathol. 2011, 225:96-105.
195. Noguchi M., Takata T., Kimura Y., Manno A., Murakami K., Koike M., Ohizumi H., Hori S., Kakizuka A. ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif. J. Biol. Chem. 2005, 280:41332-41341.
196. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
197. Koutsilieri E., Scheller C., Grunblatt E., Nara K., Li J., Riederer P. Free radicals in Parkinson's disease. J. Neurol. 2002, 249(Suppl. 2):II1-II5.
198. Labunskyy V.M., Gladyshev V.N. Role of reactive oxygen species-mediated signaling in aging. Antioxid. Redox Signal. 2012.